Rafael Holdings is a holding company with interests in clinical and early-stage pharmaceutical companies, through an investment in Cornerstone Pharmaceuticals, Inc. (Cornerstone), a cancer metabolism-based therapeutics company, a majority equity interest in LipoMedix Pharmaceuticals Ltd., a clinical stage pharmaceutical company, the Barer Institute Inc., a wholly-owned preclinical cancer metabolism research operation, an investment in Cyclo Therapeutics, Inc., a clinical-stage biotechnology company, and Rafael Medical Devices, Inc., a wholly-owned orthopedic-focused medical device company developing instruments to advance minimally invasive surgeries. We show 22 historical shares outstanding datapoints in our RFL shares outstanding history coverage, used to compute RFL market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing RFL market cap history over the course of time is important for investors
interested in comparing RFL's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of RFL versus a peer is one thing; comparing
RFL market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like RFL can fluctuate over the course of history.
With this page we aim to empower investors researching RFL by allowing them to research the RFL market cap history. |
Free RFL Email Alerts:
Video: The Importance of Market Cap
